Published in AIDS Weekly, September 9th, 2002
The results suggested that more patients who received Remune while on antiviral drug therapy (HAART) developed stronger immune responses to the HIV (70% vs. 24%, p=0.049) compared with those who received Remune plus IL-2 while on HAART. Similarly, those on HAART alone developed stronger hepatitis A antibodies (88%...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.